Lisinopril vs valsartan efficacy
Pro Research Analysisby 
Searched over 200M research papers
Antihypertensive Efficacy: Lisinopril vs. Valsartan
Multiple studies have shown that lisinopril (an ACE inhibitor) and valsartan (an angiotensin receptor blocker) are both highly effective in lowering blood pressure in patients with mild to severe hypertension. Large clinical trials found no significant difference in the reduction of systolic or diastolic blood pressure between the two drugs, whether used as monotherapy or in combination with a diuretic, and regardless of patient age or severity of hypertension Black1997Ad1997Malacco2004+3 MORE. Both medications achieved high rates of blood pressure control, with response rates typically above 80% in both groups Ad1997Malacco2004.
Tolerability and Side Effects: Cough and Adverse Events
While both drugs are effective, valsartan consistently shows a better tolerability profile, especially regarding the incidence of drug-related cough. Studies report that cough occurs much more frequently with lisinopril (ranging from 7.2% to 17.4%) compared to valsartan (typically around 1% or less) Black1997Ad1997Malacco2004+1 MORE. This side effect led to more discontinuations in the lisinopril group. Overall, valsartan is associated with fewer adverse events than lisinopril .
Special Populations: Elderly, Adolescents, and Ethnic Differences
In elderly patients, both drugs are equally effective for long-term blood pressure control, but valsartan again has a lower risk of cough . In adolescents with metabolic syndrome, both drugs provide similar blood pressure reduction, but lisinopril may be more effective in normalizing daily blood pressure and reducing left ventricular hypertrophy, while valsartan is preferred if there is intolerance to ACE inhibitors or specific metabolic concerns . In Middle Eastern populations, both drugs are effective, with a slight efficacy advantage for lisinopril, but the difference is minimal .
Heart Failure and Additional Benefits
In patients with chronic heart failure, both lisinopril and valsartan improve cardiac function and autonomic control, but valsartan may provide a greater reduction in plasma norepinephrine, suggesting a stronger effect on reducing sympathetic activity . Both drugs are safe and well tolerated in this setting De Tommasi2003Mazayev1998.
Microalbuminuria and Renal Protection
For patients with hypertension and microalbuminuria, both high-dose valsartan and lisinopril reduce urinary albumin excretion, but valsartan (and especially the combination of valsartan and lisinopril) may be more effective in normalizing microalbuminuria . This suggests potential added renal protection with valsartan or combination therapy.
Dosing Considerations
The time of day valsartan is taken (morning vs. evening) does not affect its blood pressure-lowering efficacy compared to lisinopril, and both drugs provide consistent 24-hour control .
Conclusion
Lisinopril and valsartan are equally effective in lowering blood pressure across a wide range of patients. Valsartan, however, is associated with fewer side effects, particularly cough, making it a preferred option for patients who are sensitive to this adverse effect. Both drugs are safe and effective for long-term use, with some evidence suggesting valsartan may offer additional benefits in certain patient groups, such as those with microalbuminuria or heart failure.
Sources and full results
Most relevant research papers on this topic